(-)-Coclaurine hydrochloride

CAS No. 3422-42-2

(-)-Coclaurine hydrochloride( (-)-Coclaurine hydrochloride (486-39-5 Free base) )

Catalog No. M29120 CAS No. 3422-42-2

(-)-Coclaurine hydrochloride is an antagonist of nAChRs isolated from Sarcopetalum harveyanum.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 249 In Stock
5MG 249 In Stock
10MG 369 In Stock
25MG 562 In Stock
50MG 770 In Stock
100MG 1032 In Stock
200MG 1376 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    (-)-Coclaurine hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    (-)-Coclaurine hydrochloride is an antagonist of nAChRs isolated from Sarcopetalum harveyanum.
  • Description
    (-)-Coclaurine hydrochloride is an antagonist of nAChRs isolated from Sarcopetalum harveyanum.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    (-)-Coclaurine hydrochloride (486-39-5 Free base)
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    AChR
  • Recptor
    AChR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    3422-42-2
  • Formula Weight
    321.8
  • Molecular Formula
    C17H20ClNO3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C([C@H]1C=2C(=CC(OC)=C(O)C2)CCN1)C3=CC=C(O)C=C3.Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • (±)-Acetylcarnitine ...

    (±)-Acetylcarnitine chloride (Acetyl dl-carnitine chloride) is a weak cholinergic agonist with neuroprotective properties and can be used in studies of neuritis.

  • Anisodamine B

    Anisodamine (6-beta-Hydroxyhyoscyamine) is an antagonist of muscarinic and nicotinic cholinoceptor with similar affinities at the muscarinic receptor as scopolamine and atropine.

  • CP-810123

    CP-810123 is a new alpha 7 nAChR agonist for the treatment of cognitive impairment associated with psychiatric or neurological disorders such as schizophrenia and Alzheimer's disease.